$DYN
Dyne Therapeutics, Inc.
Nasdaq · Healthcare · Pharmaceutical Preparations · Waltham, MA
DYN chart
What traders are saying about $DYN
Latest postsDyne Therapeutics, Inc. news
- Weekly Recap: Z-rostudirsen gets FDA priority review and wider Q3 loss
TradingView ·
- Dyne Therapeutics prices $375m upsized offering
scanx.trade ·
- RBC Capital Maintains Dyne Therapeutics(DYN.US) With Buy Rating, Maintains Target Price $30
Moomoo ·
- Why Dyne Therapeutics Stock Is In Focus After Wider Quarterly Losses
Simply Wall St ·
- Is Dyne Therapeutics (DYN) Undervalued After Wider Losses And FDA Priority Review?
Yahoo Finance ·
- Can Dyne Therapeutics (DYN) Justify Its Valuation Following A Wider Loss And FDA Review?
Simply Wall St ·
- Dyne Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2026
www.marketscreener.com ·
- Dyne Therapeutics Q3 Results: Loss widens 39% YoY to $1.06 per share
scanx.trade ·
- Dyne Therapeutics, Inc. reports results for the quarter ended September 30 - Earnings Summary
TradingView ·
- Dyne Therapeutics reports Q3 EPS ($1.06), consensus (88c)
TipRanks ·
- Form 8K Dyne Therapeutics Inc For: 5 November By Investing.com
Investing.com Canada ·
- Dyne Therapeutics announces Q3 2026 financial results after stock ends session up 2.7%
Traders Union ·
Dyne Therapeutics, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Net income | -$446.2 | -$317.4 | -$235.9 | -$168.1 |
| Diluted EPS | $-3.47 | $-3.37 | $-3.95 | $-3.23 |
| Total assets (year end) | $1.19B | $691.2M | $165.1M | $306.3M |
| Cash and equivalents (year end) | $893.4M | $435.4M | $121.6M | $172.1M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Dyne Therapeutics, Inc.
- Ticker
- DYN (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- Waltham, MA
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1818794
Frequently asked questions
What exchange is Dyne Therapeutics, Inc. listed on?
Dyne Therapeutics, Inc. trades on the Nasdaq under the ticker symbol DYN.
What industry is Dyne Therapeutics, Inc. in?
Dyne Therapeutics, Inc. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is Dyne Therapeutics, Inc. headquartered?
Dyne Therapeutics, Inc.'s business address on file with the SEC is in Waltham, MA.
When does Dyne Therapeutics, Inc.'s fiscal year end?
Dyne Therapeutics, Inc.'s fiscal year ends on December 31.